30.000
−0,33%
2026-10-19
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +29.7% | +30.1% | 3 / 3 | +25.0% | -0.97 pp | +0.23 pp | +34.6% | 0.01 | 4.54 | 386 | +25,0% | 40,7 | +27,8% | 4.54 | 6.88 | −34,0% |
| Pts | 4 | 4 | 12 | 12 | 4 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 30.000 (close price on 2026-10-19)EPS (TTM): 6.610
Financial charts
1.Revenue & growth
VND bn386Q2/26
1.Revenue & growth
VND bn386Q2/26
2.Profit & growth
VND bn38,7Q2/26
3.Profit mix (Penman)
VND bn179Q2/26
4.Margins & cost structure
%22.7%Q2/26
5.Returns & cash cycle
% · days98.9%Q2/26
6.Earnings quality & cash
VND bn180Q2/26
7.Asset structure
VND bn826Q2/26
8.Funding & debt health
VND bn · times826Q2/26
9.Revenue backlog
VND bn0,13Q2/26
10.Valuation
times · %4,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.933Q2/26
Adjusted EPS growth, latest quarter
29.7%
Average adjusted EPS growth, 3 quarters
30.1%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26